E-mail a Wiley Online Library Link

Marta Larrayoz, Ruben Pio, María J Pajares, Isabel Zudaire, Daniel Ajona, Oriol Casanovas, Luis M Montuenga and Jackeline Agorreta Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype EMBO Molecular Medicine 6

Version of Record online: 5 FEB 2014 | DOI: 10.1002/emmm.201303214

Thumbnail image of graphical abstract

Antiangiogenic therapies induce contrasting responses in non-small cell lung cancer (NSCLC) depending on the histological subtype. Anti-VEGFR2 therapies stabilize adenocarcinomas but induce tumor cell hyperproliferation in squamous cell carcinomas.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field